Nano-X Imaging (NNOX) Income from Continuing Operations (2019 - 2025)
Nano-X Imaging (NNOX) reported Income from Continuing Operations of 36761000.0 for Q4 2025, down 157.99% on a YoY basis from 63391926.54 in Q4 2024, and down 165.0% quarter-over-quarter from 13872000.0 in Q3 2025.
Nano-X Imaging (NNOX) Income from Continuing Operations (2019 - 2025) Analysis & Trends
Nano-X Imaging has reported Income from Continuing Operations for 7 years, with the latest figure at 36761000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations fell 157.99% year-over-year to 36761000.0; the trailing twelve-month figure through Dec 2025 stood at 78602000.0 (down 44.94% YoY), and the FY2025 full-year result was 43148000.0, down 10.84% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 36761000.0, down from 13872000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 10406000.0 in Q4 2023, with the low at 54901000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 18839050.0 across 5 years, with a median of 14060500.0 in 2024.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations plunged 163.34% — and 2023, when it surged 81.05%.
- Nano-X Imaging's Income from Continuing Operations stood at 22131000.0 in 2021, then tumbled by 148.07% to 54901000.0 in 2022, then surged by 81.05% to 10406000.0 in 2023, then slumped by 36.93% to 14249000.0 in 2024, then tumbled by 157.99% to 36761000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 36761000.0 (Q4 2025), 13872000.0 (Q3 2025), and 14558000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Nano-X Imaging | 3.62 Mn | -55.99 Mn | -3.62 Mn | -36.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.76 Mn |
| Sep 30, 2025 | -13.87 Mn |
| Jun 30, 2025 | -14.56 Mn |
| Mar 31, 2025 | -13.41 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -12.43 Mn |
| Dec 31, 2023 | -10.41 Mn |
| Sep 30, 2023 | -21.56 Mn |
| Jun 30, 2023 | -17.54 Mn |
| Mar 31, 2023 | -11.95 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -19.92 Mn |
| Jun 30, 2022 | -23.81 Mn |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -22.13 Mn |
| Sep 30, 2021 | -13.47 Mn |
| Jun 30, 2021 | -13.58 Mn |
| Mar 31, 2021 | -12.72 Mn |